Sue Siegel

Sue Siegel is a GE Corporate Officer and the CEO of healthymagination, GE’s $6 billion global commitment to provide better health for more people and is responsible for the corporate healthymagination venture fund. As a venture capitalist and General Partner at Mohr Davidow Ventures, prior to joining GE, she led life science and healthcare investments across the fields of molecular diagnostics to digital health, where convergence of disciplines and technologies drove personalized, consumer-driven and information-based healthcare. Before her venture capital career, she served as President and Director of Affymetrix, Inc., a NASDAQ-listed company that pioneered GeneChip® technology, which propelled the expansion of the genomics field and accelerated the early development of personalized medicine. Sue led the company from an early stage start up into a multi-billion market cap global company with the gold-standard gene expression platform for biomedical research. Sue’s other industry experience includes senior leadership positions with Amersham International, now part of GE Healthcare, and roles at E.I. DuPont & Co., Eastman Kodak Co., and Bio-Rad. Sue served on corporate boards including Affymetrix, Pacific Biosciences, Crescendo Biosciences, RainDance Technologies, Personalis, Analyte Health, Corventis, Navigenics, On-Q-ity, and Didimi. She was recognized as one of “The 100 Most Influential Women in Silicon Valley” and was featured in the bestselling business book: Multipliers: How The Best Leaders Make Everyone Smarter. Sue serves on the NIH NCAT’s CAN Advisory Council, is a member of President’s Council of the National Academies, serves on the IT Committee of the Board of Directors of Stanford Hospital and Clinics, and is on the Executive Committee of the Center for Science, Technology, and Society at Santa Clara University. Sue holds a Bachelor of Science in Biology from the University of Puerto Rico and a Master of Science in Biochemistry from Boston University School of Medicine. She has completed the Stanford Director’s College, executive management coursework at both Kellogg School of Management and at the Harvard Business School. She is a 2003 class member of the Henry Crown Fellowship and is a member of the Aspen Global Leadership Network at the Aspen Institute.